IDO1 and depressive symptom measurement: 1-Methlytryptophan (an inhibitor of IDO) and ketamine (an NMDA antagonist) significantly decreased depressive-like behavior by inhibiting QA-mediated NMDA signaling in rodents in an LPS-induced depression model (Aan Het Rot et al., 2012; Dobos et al., 2015).